These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 14065075)

  • 21. Comparative hypoglycemic and hypoketonemic effects of tolbutamide and glypentide in rat.
    García-Rafanell J; Lasunción MA; Morell J; Herrera E
    Rev Esp Fisiol; 1977 Jun; 33(2):103-7. PubMed ID: 877376
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Effects of Ginkgo biloba extract on the pharmacokinetics and pharmacodynamics of tolbutamide in protein-restricted rats.
    Taki Y; Hagiwara E; Hirose C; Shinozuka K; Umegaki K; Yamada S
    J Pharm Pharmacol; 2011 Sep; 63(9):1238-43. PubMed ID: 21827497
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of tuberculostatic agents on the response of serum growth hormone and immunoreactive insulin to intravenous tolbutamide, and on the half-life of tolbutamide.
    Syvälahti E; Pihlajamäki K; Iisalo E
    Int J Clin Pharmacol Biopharm; 1976 Mar; 13(2):83-9. PubMed ID: 1254383
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Immediate effects of intravenous injections of tolbutamide and insulin on blood glucose and amino acids.
    DEMEUTTER RC; KHACHADURIAN AK; MARBLE A
    Proc Soc Exp Biol Med; 1958 Oct; 99(1):33-5. PubMed ID: 13601756
    [No Abstract]   [Full Text] [Related]  

  • 25. A DOUBLE-BLIND TRIAL OF AN ANABOLIC STEROID IN EIGHTEEN ELDERLY WOMEN.
    BEW K
    Practitioner; 1965 Apr; 194():530-4. PubMed ID: 14273203
    [No Abstract]   [Full Text] [Related]  

  • 26. MEASUREMENT OF GLUCOSE DISPOSAL RATES IN NORMAL AND DIABETIC HUMAN SUBJECTS AFTER REPEATED INTRAVENOUS INJECTIONS OF GLUCOSE.
    STREETEN DH; GERSTEIN MM; WOOLFOLK D; DOISY RJ
    J Clin Endocrinol Metab; 1964 Aug; 24():761-74. PubMed ID: 14202755
    [No Abstract]   [Full Text] [Related]  

  • 27. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
    Rosak C; Haupt E; Walter T; Werner J
    Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Behavior of free fatty acids in the serum following tolbutamide administration in normal persons, dietetically regulated and insulin-dependent diabetics of differing body weight and differing initial blood sugar levels].
    Ulrich E; Frank I; Kujat G; Müller G; Seige K
    Endokrinologie; 1969; 54(5):442-52. PubMed ID: 5359974
    [No Abstract]   [Full Text] [Related]  

  • 29. THE INSULIN-LIKE ACTIVITY IN SERUM DETERMINED BY THE RAT EPIDIDYMAL FAT METHOD. V. THE DISTRIBUTION OF INSULIN-LIKE ACTIVITY IN ELECTROPHORETICALLY-SEPARATED SERUM PROTEIN FRACTIONS FROM NORMAL FASTING SUBJECTS AND THE EFFECT OF INGESTION OF GLUCOSE.
    LYNGSOE J
    Acta Med Scand; 1964 Apr; 175():401-8. PubMed ID: 14149646
    [No Abstract]   [Full Text] [Related]  

  • 30. Studies on the disposition of blood glucose; a comparison of insulin and orinase.
    ASHMORE J; CAHILL GF; EARLE AS; ZOTTU S
    Diabetes; 1958; 7(1):1-8. PubMed ID: 13490233
    [No Abstract]   [Full Text] [Related]  

  • 31. [GLUCOSE METABOLISM IN OLD AGE: THE TOLBUTAMIDE TEST].
    SANTAMBROGIO S; CONTI F; DELBONO P
    Osp Maggiore; 1965 May; 60():420-8. PubMed ID: 14343651
    [No Abstract]   [Full Text] [Related]  

  • 32. ORAL HYPOGLYCEMIC DRUGS: COMPARATIVE EVALUATION OF TOLBUTAMIDE, CHLORPROPAMIDE AND PHENFORMIN.
    MOSS JM; DELAWTER DE; GALLAGHER EJ
    Med Times; 1964 Jul; 92():645-54. PubMed ID: 14184191
    [No Abstract]   [Full Text] [Related]  

  • 33. Blood sugar and anti-insulin serum levels of actively and passively immunized rabbits. Comparison of the effects of tolbutamide and insulin.
    HIRATA Y; BLUMENTHAL HT
    Diabetes; 1962; 11(Suppl)():26-33. PubMed ID: 13954744
    [No Abstract]   [Full Text] [Related]  

  • 34. Metformin for treatment of antipsychotic-induced weight gain in a South Asian population with schizophrenia or schizoaffective disorder: A double blind, randomized, placebo controlled study.
    de Silva VA; Dayabandara M; Wijesundara H; Henegama T; Gunewardena H; Suraweera C; Hanwella R
    J Psychopharmacol; 2015 Dec; 29(12):1255-61. PubMed ID: 26510448
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [CONTRIBUTION TO THE STUDY OF THE TOXIC EFFECTS DUE TO HYPOGLYCEMIC SULFONYLUREAS].
    CIAMMAICHELLA A; CANTERA N
    Minerva Med; 1964 Mar; 55():657-64. PubMed ID: 14140236
    [No Abstract]   [Full Text] [Related]  

  • 36. INSULINOMA WITH SYMPTOMS FOR THIRTY YEARS.
    BLACK KO; BIRNSTINGL MA
    Proc R Soc Med; 1964 Aug; 57(8):675-6. PubMed ID: 14195855
    [No Abstract]   [Full Text] [Related]  

  • 37. AN EVALUATION OF TOLBUTAMIDE IN THE TREATMENT OF CHRONIC OCCLUSIVE ARTERIAL DISEASE OF THE LOWER EXTREMITIES.
    ROSS JV
    Angiology; 1964 Jul; 15():316-7. PubMed ID: 14178000
    [No Abstract]   [Full Text] [Related]  

  • 38. ACETOHEXAMIDE ('DIMELOR') IN DIABETES.
    HERMAN M; JACKSON WP
    S Afr Med J; 1964 Jul; 38():519-22. PubMed ID: 14182168
    [No Abstract]   [Full Text] [Related]  

  • 39. The effect of oral sulphonylureas on blood glucose and insulin.
    Adadevoh BK; Bolodeoku JO
    Ghana Med J; 1973 Dec; 12(4):360-5. PubMed ID: 4282692
    [No Abstract]   [Full Text] [Related]  

  • 40. Metformin for treatment of antipsychotic-induced weight gain: a randomized, placebo-controlled study.
    Wang M; Tong JH; Zhu G; Liang GM; Yan HF; Wang XZ
    Schizophr Res; 2012 Jun; 138(1):54-7. PubMed ID: 22398127
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.